Department of Public Health Sciences, Senior ICES Scientist, Queen's University, Kingston, ON, Canada.
Department of Anesthesiology and Perioperative Medicine, Queen's University, Kingston, ON, Canada.
Can J Anaesth. 2022 Aug;69(8):934-944. doi: 10.1007/s12630-021-02091-2. Epub 2021 Aug 25.
Canadian seniors who undergo hip and knee arthroplasty often experience significant postoperative pain, which could result in persistent opioid use. We aimed to document the impact of preoperative opioid use and other characteristics on postoperative opioid prescriptions in elderly patients following hip and knee replacement before widespread dissemination of opioid reduction strategies.
We conducted a historical cohort study to evaluate postoperative opioid use in patients over 65 yr undergoing primary total hip and knee replacement over a ten-year period from 1 April 2006 to 31 March 2016, using linked de-identified Ontario administrative data. We determined the use of preoperative opioids and the duration of postoperative opioid prescriptions (short-term [1-90 days], prolonged [91-180 days], chronic [181-365 days], or undocumented).
The study included 49,638 hip and 85,558 knee replacement patients. Eighteen percent of hip and 21% of knee replacement patients received an opioid prescription within 90 days before surgery. Postoperatively, 51% of patients filled opioid prescriptions for 1-90 days, while 24% of hip and 29% of knee replacement patients filled prescriptions between 6 and 12 months, with no impact of preoperative opioid use. Residence in long-term care was a significant predictor of chronic opioid use (hip: odds ratio [OR], 2.64; 95% confidence interval [CI], 1.93 to 3.59; knee: OR, 2.46; 95% CI, 1.75 to 3.45); other risk factors included female sex and increased comorbidities.
Despite a main goal of joint arthroplasty being relief of pain, seniors commonly remained on postoperative opioids, even if not receiving opioids before surgery. Opioid reduction strategies need to be implemented at the surgical, primary physician, long-term care, and patient levels. These findings form a basis for future investigations following implementation of opioid reduction approaches.
在广泛推广阿片类药物减量策略之前,我们旨在记录加拿大接受髋关节和膝关节置换术的老年人患者术前使用阿片类药物和其他特征对术后阿片类药物处方的影响,这些老年人术后通常会经历明显的疼痛,这可能导致持续使用阿片类药物。
我们进行了一项历史队列研究,使用链接的匿名安大略省行政数据,评估了 2006 年 4 月 1 日至 2016 年 3 月 31 日期间十年内接受初次全髋关节和全膝关节置换术的 65 岁以上患者的术后阿片类药物使用情况。我们确定了术前使用阿片类药物的情况以及术后阿片类药物处方的持续时间(短期[1-90 天]、长期[91-180 天]、慢性[181-365 天]或未记录)。
该研究包括 49638 例髋关节置换术和 85558 例膝关节置换术患者。18%的髋关节置换术和 21%的膝关节置换术患者在手术前 90 天内接受了阿片类药物处方。术后,51%的患者在 1-90 天内服用阿片类药物处方,而 24%的髋关节置换术和 29%的膝关节置换术患者在 6-12 个月内服用处方,术前使用阿片类药物对其没有影响。长期护理居住是慢性阿片类药物使用的一个显著预测因素(髋关节:优势比[OR],2.64;95%置信区间[CI],1.93 至 3.59;膝关节:OR,2.46;95%CI,1.75 至 3.45);其他风险因素包括女性和合并症增多。
尽管关节置换术的主要目标是缓解疼痛,但老年人即使在手术前没有接受阿片类药物治疗,也通常仍需服用术后阿片类药物。需要在手术、初级医生、长期护理和患者层面实施阿片类药物减量策略。这些发现为实施阿片类药物减量方法后的未来研究奠定了基础。